A detailed history of Weaver Consulting Group transactions in Veru Inc. stock. As of the latest transaction made, Weaver Consulting Group holds 49,425 shares of VERU stock, worth $28,666. This represents 0.01% of its overall portfolio holdings.

Number of Shares
49,425
Previous 37,488 31.84%
Holding current value
$28,666
Previous $31,000 22.58%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.77 - $1.04 $9,191 - $12,414
11,937 Added 31.84%
49,425 $38,000
Q2 2024

Jul 12, 2024

BUY
$0.76 - $1.79 $11,552 - $27,208
15,200 Added 68.2%
37,488 $31,000
Q1 2024

Apr 16, 2024

BUY
$0.37 - $0.72 $8,246 - $16,047
22,288 New
22,288 $15,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Weaver Consulting Group Portfolio

Follow Weaver Consulting Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.